N-α-Z-D-arginine

N-α-Z-D-arginine is an Nα-benzyloxycarbonyl (Z) protected D-arginine derivative, bearing a stereogenic center at the α-carbon and a guanidinium-containing side chain characteristic of arginine. The molecule combines a protected carboxylate function typical of amino acid building blocks with a carbamate-protected α-amino group, while the D-configuration provides defined stereochemical control for downstream peptide construction. The Z carbamate can be removed under hydrogenolysis-compatible conditions, enabling access to the free α-amine for coupling, while the side-chain guanidine is predisposed to salt formation and selective functional manipulation depending on reaction environment. As a chiral amino acid intermediate, N-α-Z-D-arginine participates in peptide coupling chemistry and supports stereochemically defined incorporation of D-arginine motifs into peptide and peptidomimetic scaffolds.

1. Peptide Synthesis

N-α-Z-D-arginine is applied in peptide synthesis workflows where a protected α-amino group and a D-configured stereocenter enable controlled amide bond formation. The Z carbamate protects the α-amine during activation of the carboxyl group and coupling to activated amino acid partners, while the arginine side chain provides a guanidinium functionality that can be retained for ionic interactions in the growing peptide. The D-arginine stereochemistry supports preparation of stereochemically defined peptide analogs for studying backbone stereochemistry effects and protease resistance trends. Z deprotection and subsequent coupling cycles can be used to generate D-arginine-containing sequences for peptide building block preparation and iterative scaffold assembly.

2. Chemical Biology

N-α-Z-D-arginine is utilized in chemical biology research to introduce a D-arginine motif into peptide probes, affinity ligands, or receptor-binding mimic constructs. The guanidinium side chain enables strong electrostatic and hydrogen-bonding interactions, while the protected α-amino group supports incorporation into larger biomolecule-binding frameworks without premature side reactions. Z protection provides a stable handle during synthesis of conjugatable intermediates, after which deprotection can enable further functionalization or attachment to biomolecular targets. D-configuration can be leveraged to probe stereochemical recognition, binding selectivity, and stability of arginine-dependent interactions in biochemical assays.

3. Bioconjugation Chemistry

N-α-Z-D-arginine is suitable for bioconjugation chemistry where an arginine-derived cationic side chain can drive conjugate solubility and interaction with negatively charged biomolecular surfaces. The Z-protected α-amino group supports sequential derivatization steps, including conversion into coupling-ready intermediates for attachment to carriers such as peptides, polymers, or biomolecule-reactive scaffolds. The guanidinium functionality can be maintained to preserve charge characteristics during conjugate assembly, supporting downstream formation of labeled or immobilized constructs. D-arginine incorporation can further be used to tune conjugate stability and stereochemical behavior in analytical and materials-oriented biochemical workflows.

4. Protected Amino Acid Chemistry

N-α-Z-D-arginine is employed as a protected amino acid building block for protected amino acid synthesis and controlled deprotection strategies in fine chemical manufacturing and research-grade intermediate preparation. The Z carbamate on the α-amino group provides orthogonal protection relative to many side-chain functionalization approaches, allowing selective transformations while maintaining the arginine side chain for later guanidinium-compatible steps. The defined D stereochemistry supports stereoselective assembly of chiral peptide fragments and enables downstream compatibility with standard peptide coupling reagents. The compound can serve as a chiral amino acid intermediate for producing D-arginine-containing peptides, peptidomimetics, and stereochemically defined library members.

5. Pharmaceutical Intermediate Preparation

N-α-Z-D-arginine is relevant to pharmaceutical intermediate preparation where D-amino acid incorporation is used to generate stereochemically defined peptidic or peptidomimetic fragments for structure-activity relationship studies. The combination of a removable Z protecting group and the guanidinium side chain supports stepwise synthesis of charged peptide domains that can be assembled into larger drug-like candidates or screening libraries. The protected α-amino functionality facilitates manufacturing-compatible peptide coupling sequences, while the D-configuration provides a controllable stereochemical element for analog generation. The resulting intermediates can be carried forward into downstream synthetic routes that require robust handling of chiral amino acid units and predictable deprotection-to-coupling transitions.

6. Analytical Research Standards

N-α-Z-D-arginine is applied in analytical research as a stereochemically defined reference material and derivatization precursor for monitoring D-arginine-containing peptides and related amino acid derivatives. The Z-protected α-amino group and arginine side-chain guanidinium enable structured chemical handling during sample preparation, supporting consistent derivatization patterns for chromatographic or mass spectrometric workflows. The D stereochemistry helps distinguish enantiomeric or diastereomeric species during method development and validation of peptide stereochemical composition. The compound therefore supports analytical method refinement for amino acid derivatization, peptide coupling chemistry verification, and quality control of D-arginine-containing synthetic intermediates.

1. Oleic acid and glucose regulate glucagon-like peptide 1 receptor expression in a rat pancreatic ductal cell line

2. An Isolated TCR αβ Restricted by HLA-A* 02: 01/CT37 Peptide Redirecting CD8+ T Cells to Kill and Secrete IFN-γ in Response to Lung Adenocarcinoma Cell Lines

3. P-selectin and Complement’s Role in a Neonatal Model of Germinal Matrix Hemorrhage-Induced Secondary Injury

4. The effect of B-type allatostatin neuropeptides on crosstalk between the insect immune response and cold tolerance

5. Novel Peptide-Based PD1 Immunomodulators Demonstrate Efficacy in Infectious Disease Vaccines and Therapeutics